Back to Newsroom
Back to Newsroom

Lifshitz Law PLLC Announces Investigations of RFP, FSTX, GMTX, and SMED

Saturday, August 13, 2022 7:07 PM
Topic:
Lawsuits

NEW YORK, NY / August 13, 2022 / ACCESSWIRE /

Resolute Forest Products Inc. (NYSE:RFP)

Lifshitz Law PLLC announces an investigation into possible breach of fiduciary duties in connection with the sale of RFP to The Paper Excellence Group, through its wholly-owned subsidiary Domtar Corporation ("Domtar"). Under the terms of the agreement, RFP's shareholders will receive approximately $20.50 in cash per RFP share owned.

If you are an RFP investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or email at [email protected].

F-star Therapeutics, Inc (NASDAQ:FSTX)

Lifshitz Law PLLC announces investigation into possible breach of fiduciary duties in connection with the sale of FSTX to invoX Pharma for $7.12 per share.

If you are an FSTX investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

Gemini Therapeutics, Inc. (NASDAQ:GMTX)

Lifshitz Law PLLC announces investigation into possible breach of fiduciary duties in connection with GMTX's agreement to merge with Disc Medicine, Inc. Under the terms of the merger agreement, Pre-merger Gemini shareholders are expected to own approximately 28% of the combined company and pre-merger Disc shareholders are expected to own approximately 72% of the combined company.

If you are a GMTX investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

Sharps Compliance Corp. (NASDAQ:SMED)

Lifshitz Law PLLC announces an investigation into possible breach of fiduciary duties in connection with the sale of SMED to an affiliate of Aurora Capital Partners for $8.75 per share.

If you are a SMED investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or email at [email protected].

ATTORNEY ADVERTISING.© 2022 Lifshitz Law PLLC. The law firm responsible for this advertisement is Lifshitz Law PLLC, 1190 Broadway, Hewlett, New York 11557, Tel: (516)493-9780. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact:

Joshua M. Lifshitz, Esq.
Lifshitz Law PLLC
Phone: 516-493-9780
Facsimile: 516-280-7376
Email: [email protected]

SOURCE: Lifshitz Law Firm, P.C.

Topic:
Lawsuits
Back to newsroom
Back to Newsroom